ISSN: 2329-6771

Journal of Integrative Oncology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
 
 
 
 

Editorial Board

Homer S Black

Editor-in-Chief
Homer S Black
Professor
Department of Dermatology
Baylor College of Medicine
USA

Biography :

Dr. Black earned a Ph.D. in biochemistry from Louisiana State University in 1964. He earned a B.Sc. in animal science from Texas A&M University in 1956. He also holds a M.Ed. from Sam Houston State University; and a M.S.Admin. (business/health science management) from the University of Houston. He was a Senior Fulbright Scholar at the Photobiology Centre, University of Dundee, Scotland. Dr. Black has been a member of a number of scientific societies including the Sigma Xi, American Association of Cancer Research, American Oil Chemists’ Society, European Society for Photobiology, Photomedicine Society, and the American Society for Photobiology. He served as Treasurer in the latter. Dr. Black is also a member of the Institute of Professional Managers and was Chairman of the Board of Regents for the Academy of Administrative Managers. His research interests have focused upon the chemopreventive or pro-carcinogenic effects of antioxidants and dietary fat in UV-carcinogenesis.

 

 Biography
Research Interest :

Pro-carcinogenic effects of antioxidants and dietary fat in UV-carcinogenesis
 

 

 Research Interest
 Network
 Acceptance Letter
Xiong-Zhi Wu

Editor-in-Chief
Xiong-Zhi Wu
Associate Professor
Tianjin Medical University
China

 

 

Biography :

Dr. Xiong-Zhi Wu obtained his Ph.D. degree in 2005 at Medical School of West China, Sichuan University. Dr. Wu worked as associate Prof. of Treatment and the advisor of postgraduate in Tianjin Medical University Cancer Institute and Hospital. Dr. Wu is the vice director of integrative oncology department. Dr. Wu was award the title “creative talented Scholar” by Tianjin government and the title “outstanding talented Scholar in new century” by Tianjin Medical University, and Cancer Institute and Hospital. He is the commissioner of Committee of Rehabilitation and Palliative care. China, vice director of Committee of Rehabilitation and Palliative care. Tianjin, China, and the editor of international journals, such as Research Journal of Biological Sciences and International Journal of Molecular Medicine and Advance Sciences. He is the reviewer of manuscripts for many international Journals, such as European Surgical Research, Lancet infectious diseases, International Journal of Pharmaceutics, Histology and Histolopathology, Acta Pharmacologica Sinica. Dr. Wu published more that 50 papers and two books, and 12 papers were published in international journals and were index by SCI.

 

 

 Biography
Research Interest :

Integrative Oncology.

 

 

 Research Interest
 Network
Judith A. Smith

Executive Editor
Judith A. Smith
Associate Professor
Director of Pharmacology Research
Department of Gynecology Oncology
The University of Texas
USA
Read Interview session with Judith A. Smith

Biography :

Dr. Judith A. Smith is an Associate Professor in the Department of Gynecologic Oncology & Reproductive Medicine in the Division of Surgery at The University of Texas MD Anderson Cancer Center in Houston (UTMDACC), Texas and Adjunct Associate Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at The University of Texas Health Science Center at Houston Medical School. Dr. Smith received a Bachelor of Science in Pharmacy and her Doctor of Pharmacy degree from Union University Albany College of Pharmacy. She completed residency in Pharmacy Practice and Oncology Pharmacy Practice at the National Institutes of Health followed by a fellowship in Clinical Pharmacology at UTMDACC. She has been Board Certified in Oncology Pharmacy. Her research focus is on drug development for gynecologic cancers and conditions with a specific focus on integration of nutritional supplements and herbs with traditional chemotherapy.

 Biography
Research Interest :

Gynecologic Oncology

 Research Interest
 Network
 Acceptance Letter
Yoshiaki Omura

Yoshiaki Omura
Department of Family & Community Medicine
New York Medical College
USA

Biography :

Dr. Omura (M.D) Yokohama City University, with internship at Toyoko University Hospital, Tokyo and Sc.D. - in Pharmaco-Electrophysiology of Single Cardiac Cells, Columbia University, New York), far-reaching expertise is rooted in a strong academic background involving an unusual combination of fields including experimental physics (B.S. in Applied Physics, Waseda University, Tokyo--the founder of the SONY Corporation graduated from the same Engineering School--and three years in Graduate Experimental Physics, non-matriculated, Columbia University), medical electronics (Research Professor, Department of Electrical Engineering, Manhattan College, where he introduced the first course in Biomedical Electronics), and basic and clinical medicine (Research Fellow in Cardiovascular Surgery, and Residency at the Cancer Research Hospital, Columbia University) from both Western and Oriental perspectives (several teaching and research Professorship appointments at various universities in Japan and the U.S.).

 Biography
Research Interest :

Acupuncture & Electro-Therapeutics Research, Integrative Oncology.
 

 Research Interest
 Network
 Acceptance Letter
Ming Tan

Ming Tan
Associate Professor of Oncologic Sciences
Mitchell Cancer Institute
USA

Biography :

Ming Tan, M.D., Ph.D., is an Associate Professor and a Scholar at Mitchell Cancer Institute, University of South Alabama. Upon earning his Ph.D. degree in cancer biology from the University of Texas Anderson Cancer Center in 2000, he continued his research on the mechanisms of oncogene induced cancer progression and therapeutic resistance as a postdoctoral fellow. He joined the Faculty at Mitchell Cancer Institute at the University of South Alabama in 2007, where he directed a research program on metabolism and cancer, mechanism of cancer cell therapeutic resistance, invasion and metastasis, and microRNA in cancer development.

 Biography
Research Interest :

Oncogenes
Cancer metabolism
Signal transduction
Targeted cancer therapy

 Research Interest
 Network
 Acceptance Letter
Marja T. Nevalainen

Marja T. Nevalainen
Associate Professor
Cancer Biology
Thomas Jefferson University
USA

Biography :

Nevalainen completed her MD in the University of Turku, School of Medicine, Finland, in 1992, became a licensed physician in 1993 and received her PhD in Cell Biology from the University of Turku in 1997. Dr. Nevalainen served in a variety of internships in medicine, pediatrics, anesthesiology and surgery and in a series of fellowships including the Finnish Academy of Science Fellowship and a WHO fellowship. From 2002 to 2006 she was an Assistant Professor in the Department of Oncology at Lombardi Comprehensive Cancer Center in Georgetown, Washington and is currently Associate Professor in the department of Cancer Biology at Kimmel Cancer Center at Thomas Jefferson University and the Associate Director of Education at Kimmel Cancer Center. Dr. Nevalainen is an American Cancer Society Research Scholar and a recipient of various awards for her research in prostate cancer.

 Biography
Research Interest :

Endocrine related cancers, prostate cancer, hormone action, growth factor signaling, Stat transcription factors, biomarkers, translational cancer research, therapy development, target validation.

 Research Interest
 Network
Cathie Garnis

Cathie Garnis
Department of Surgery
University of British Columbia
USA

 

Biography :

Dr. Cathie Garnis is an Assistant Professor and Director of Research for the Division of Otolaryngology (Department of Surgery) at the University of British Columbia. She completed her PhD from the University of British Columbia in 2005 and went on to a post-doctoral fellowship with Dr. Philip Sharp at the MIT Center for Cancer Research; Her research has focused on the molecular basis of development and progression for head and neck cancers (with a particular emphasis on oral malignancy). Her work is focused on deriving new knowledge regarding tumor biology and the creation of molecular tools that can be effectively applied to guide clinical management of cancer patients. Dr. Garnis has published over 25 peer-reviewed articles and book chapters and her work has been cited more than 600 times. She has served on several national and international grant panels and is on the editorial board of Data set Papers in Oncology.

 Biography
Research Interest :

Molecular basis of development and progression for head and neck cancers

 Research Interest
 Network
 Acceptance Letter
Tod W. Speer

Tod W. Speer
Assitant Professor
Department of Human Oncology
University of Wisconsin
USA

Biography :

Tod W.Speer is currently working as clinical Assistant Professor, Human Oncology at the University of Wisconsin School of Medicine, Madison, Wisconsin.He has been honoured for his valuable contributions in Human oncology research. He is also contributing himself for many public and community services.

 

 Biography
Research Interest :

Human Oncology

 Research Interest
 Network
Wanchang Cui

Wanchang Cui
Research Associate
Department of Radiation Oncology
University of Maryland
USA

Biography :

Dr. Cui is a Research Associate at the Department of Radiation Oncology, University of Maryland School of Medicine. He received his PhD from the University of Rochester in 2008 and went on to a postdoctoral fellowship at the Johns Hopkins Bloomberg School of Public Health. After finishing the first postdoctoral training, he started his second postdoctoral training with Dr. Thomas MacVittie at the University of Maryland and finally joined the faculty there. His expertise covers molecular biology, genomics, radiation toxicity and clinical supporting of non-human primate related research. His current research is focused on defining molecular mechanisms of ionizing radiation induced normal tissue damage, mechanism of action of radiation mitigators and biomarkers of radiation induced toxicity in non-human primate models.

 Biography
Research Interest :

Radiation Oncology

 Research Interest
 Network
Xiongbin Lu

Xiongbin Lu
Department of Cancer Biology
University of Texas
USA

Biography :

Dr. Lu is Assistant Professor of Cancer Biology at The University of Texas M. D. Anderson Cancer Center. Research in Dr. Lu’s laboratory has been focused on the identification of key regulators in the DNA damage response and repair pathways. He is the principle investigator in a number of research grants from the National Institutes of Health (R01, R03, P20), American Cancer Society (ACS Research Scholar Grant), American Federation for Aging Research, AT Children’s Project and University of Texas Stars Plus award.  Dr. He has been active in professional activities. He has served as a member of review panels for DOD Breast Cancer Idea Award, Cancer Research UK, UK Medical Research Council, Bankhead-Coley Cancer Research Program and James & Esther King Biomedical Research Program. He is Associate Editor for American Journal of Cancer Research and is in editorial board for Frontiers in Pharmacotherapy of Inflammation. Dr. Lu has been served as a reviewer for more than 20 biomedical journals. Before joining MD Anderson Cancer Center, Dr. Lu was an assistant professor of Biology and a target PI of South Carolina Colon Cancer Center at the University of South Carolina-Columbia from 2007 to 2010, and a Research Assistant Professor at Baylor College of Medicine. Dr. Lu received his Ph.D. in 1998 from Chinese Academy of Sciences and completed his postdoctoral training in 2003 at Baylor College of Medicine.

 Biography
Research Interest :

Molecular biology and cancer biology

 Research Interest
 Network
Ajay P. Singh

Ajay P. Singh
Department of Oncologic Sciences
Mitchell Cancer Institute
USA

Biography :

Ajay Singh, Ph.D., is an Assistant Professor of Oncologic Sciences at University of South Alabama Mitchell Cancer Institute (USAMCI). Dr. Singh received a Master’s degree in Biotechnology from Aligarh Muslim University and graduated from the Devi Ahilya University, Indore, India. He completed a short post-doctoral fellowship in the Department of Biochemistry and Molecular Biology at University of Nebraska Medical Center, Omaha, Nebraska. He later attained a research faculty position in the same department, and joined USAMCI in 2009 as a tenure-track faculty. Studies in Dr. Singh’s laboratory have been supported through state and federal grants. He was awarded funds from State of Nebraska for two consecutive years (2007 and 2008) and one grant each from National Cancer Institute (NCI) and Department of Defense (DOD) to support his research. Dr. Singh serves on regional, national and international panels to review research proposals for funding considerations.

 Biography
Research Interest :

Major focus of Dr. Singh’s research is to delineate the molecular mechanisms underlying the aggressive and therapy-resistant behavior of cancer cells. In particular, his lab is investigating the role of microRNAs and tumor microenvironment in facilitating growth, epithelial to mesenchymal transition (EMT), metastasis and drug-resistance of pancreatic and prostate tumor cells. Earlier studies of Dr. Singh identified a mucin gene, MUC4, to be of pathological significance in pancreatic cancer progression and metastasis. MUC4 is an aberrantly expressed glycoprotein in pancreatic cancer exhibiting no expression in the normal pancreas. Recently, his team identified a novel microRNA-mediated mechanism involved in its deregulation in pancreatic cancer. Dr. Singh’s research has also revealed that CXCL12-CXCR4 signaling axis, an exemplary of tumor-microenvironment interaction, promotes drug-resistance in pancreatic cancer cells. In additional studies, his group has identified protein phosphatase 2A (PP2A) as a novel therapeutic target in prostate cancer. They have shown that PP2A activity is inversely associated with androgen-independent growth of prostate cancer cells through a novel mechanism, whereby loss of PP2A-mediated checkpoints leads to the activation of Akt and ERK and partially sustains androgen receptor signaling under steroid-deprived condition. The findings from Dr. Singh’s lab offer potential therapeutic implications for microRNAs, PP2A and tumor-microenvironment in highly aggressive and therapy-resistant pancreatic and/or prostate malignancies.

 Research Interest
 Network
Yaguang Xi

Yaguang Xi
Mitchell Cancer Institute
University of South Alabama
USA

Biography :

Yaguang Xi serves as an Assistant Professor of oncologic sciences at the Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA. In 2003, Dr. Xi earned his Ph.D. degree in cancer biology from the Peking University after he accomplished the medical training. His expertise covers molecular biology, cell biology, genomics, genetics, oncology, and bioinformatics. Currently, Dr. Xi focuses on characterizing micro-RNA biomarkers and validating their important roles in cancer development, tumor metastasis, chemotherapy, and prevention.

 Biography
Research Interest :

Cell biology, genomics, genetics, oncology

 Research Interest
 Network
 Acceptance Letter
Thiruvengadam Arumugam

Thiruvengadam Arumugam
Department of Cancer Biology
University of Texas
USA

Biography :

The goal of his research is to improve the treatment of pancreatic cancer and better patient outcome from this aggressive cancer. Resistance to chemo and radiotherapy is one of the major problems in pancreatic cancer management. Gemcitabine is the standard chemotherapy for this cancer and it has very meager benefits initially, and after that this drug is completely ineffective. His recent study showed that most of the pancreatic cancer cells lines are resistance to gemcitabine and other drugs, suggesting resistant mechanism is global. Resistant cells has mesenchymal phenotype, suggested EMT (Epithelial to Mesenchymal Transition) is one of the phenomena behind the drug resistance. His another approach to understand the drug resistance is identifying the gene expression that will be induced after gemcitabine treatment, this study revealed number of cell cycle regulator, de-toxifying molecules, anti-apoptotic molecules and also lots of novel genes that was not reported elsewhere and related to cancer stem cell survival. He is extending this study further with patient tissue xenograft, aiming to personalized medicine. Another focus of his research is to develop blocker for S100-RAGE interactions. This molecule plays a crucial role in tumor growth, angiogenesis, metastasis and also drug resistance. RAGE is a central mediator of inflammation in tumor tissue, vascular, neuronal, renal complications and other pathological conditions. He engaged in developing novel small peptide to block this RAGE mediated pathological function. Apart from my laboratory research he is also interested in optical imaging for tumor growth, metastasis and gene delivery.

 Biography
Research Interest :

Pancreatic Cancer, Optical imaging for tumor growth, Metastasis and gene delivery
 

 Research Interest
 Network
Vijaya Ramachandran

Vijaya Ramachandran
Department of Cancer Biology
University of Texas
USA

Biography :

Vijaya Ramachandran completed Doctorate in Medical Biochemistry at University of Madras, Chennai.
Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX.

 Biography
Research Interest :

Microarray profiling in pancreatic cancer, differential expression pattern of genes

 Research Interest
 Network
Goyal P K

Goyal P K
Professor
Radiation & Cancer Biology Laboratory
Department of Zoology
Central University of Rajasthan
India

Biography :

Dr. P. K. Goyal is serving as Professor in Department of Zoology, Chief of Radiation & Cancer Biology as well as Director, Life Sciences at University of Rajasthan, Jaipur. He is honored as the President of  Indian Society of Radiation Biology and President  Indo Global Health Care Research Foundation. He has been elected as the Member of Advisory Committee of  World Cancer Research Forum for plant based research on Cancer management and Councilor of Asian Congress on Radiation Research.
 In recognition for his valuable and significant contribution in radiation and cancer research, he has been the recipient of several prestigious International/National awards such as Yuva Ratana Award (1985), TOYP Award (1986), ICRR Non-Tenured Scientist Award, Ireland (1999), ISHEER Award (2001), Shiksha Rattan Puruskar (2007), Samaj Rattan Puruskar (2008), Rastriya Gaurav Award (2009) and Excellence Research Award (2010). Recently, he has been conferred with Life Time Achievement Award during International Conference on Emerging Frontiers & Challenges in Radiation Biology held at Bikaner for his outstanding contribution in Radiation and Cancer research.
Dr. Goyal has published more than 160 research papers in various national and international scientific peer reviewed journals related to radiation & cancer biology. He participated, delivered lectures and chaired scientific sessions at various national and international conferences/ symposia/ workshop in different parts of the India as well as in several countries like U.K., Canada, Germany, England, Austria, Australia, Thailand, Singapore, Netherlands, France, Luxemburg, USA, Korea, Belgium, Poland etc. He has organized several International/National Conferences, symposia and workshops.
 

 Biography
Research Interest :

Integrative Oncology

 Research Interest
 Network
Manjeshwar Shrinath Baliga

Manjeshwar Shrinath Baliga
Research and Development
Father Muller Medical College
India
 

Biography :

Dr. Baliga has done his Ph.D.  in Evaluation of the antineoplastic and radiosensitizing activities of Sapthaparna (Alstonia scholaris) in vivo and in vitro (Department of Radiobiology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576119, India, October 2003). He completed his Post Doctoral Fellow in November 2003 to September 2004, Department of Dermatology, University of Birmingham at Alabama, Birmingham, USA. He completed his Post Doctoral Research Associate: October 2004 to September October 2006, Department of Human Nutrition, University of Illinois at Chicago, USA.

 Biography
Research Interest :

Integrative Oncology.

 Research Interest
 Network
Sajani  S. Lakka

Sajani  S. Lakka
Associate Professor
Section of Hematology/Oncology
Department of Medicine
University of Illinois
USA

Biography :
 Biography
Research Interest :

1) Exporing the molecular mechanisms wherby SPARC modulates cell fate and tumorgenesis in brain tumors.
2) Identifying the role of mir-203 in brain tumor growth and differentiation.

 

 Research Interest
 Network
Simona Pisanti

Simona Pisanti
Researcher
Department of Medicine and Surgery
University of Salerno
Italy

Biography :

Dr. Simona Pisanti is a researcher at University of Salerno in Department of Medicine and Surgery. She completed her Master degree in the field of Biotechnology in the year of 2002 and earned PhD in Molecular Oncology and Endocrinology in 2008. She was a Research associate (postdoctoral fellow) funded by Italian Foundation for Cancer Research (FIRC) for the project “Role of the endocannabinoid system in angiogenesis” at the Department of Pharmaceutical Sciences, University of Salerno as an Adjunct Professor at University of Naples and University of Salerno. She is a Researcher at the University of Salerno, Department of Medicine and Surgery, Experimental medicine and pathophysiology. Dr. Pisanti has been the author of 34 papers on peer-reviewed international journals, 7 conferences as invited speaker, 36 abstracts and 6 conference proceedings on peer-reviewed international journals, a book, a chapter in a book. H index 18. IF (2012) 203.908. She has also reviewed for international journals and research councils; and is the winner of 6 prizes, such as Best junior researcher in 2006, Tihany, Hungary; Excellent researcher in 2011, Salerno; Start Cup Campania 2013.

 Biography
Research Interest :

Angiogenesis in cancer and other diseases; Role of the endocannabinoid system in cancer and angiogenesis; Role of the isoprenoid pathway in cancer and angiogenesis; new targets and strategies to treat cancer in several cancer models: breast cancer, colon cancer, glioblastoma and melanoma; Immunotherapy of cancer: natural killer cells; Multiple sclerosis: immune regulation and novel drugs

 Research Interest
 Network
AMIT KUMAR TYAGI

Amit Kumar Tyagi
Department of Experimental Therapeutics
The University of Texas MD Anderson Cancer Center
USA

Biography :

Dr Amit Kumar Tyagi received his PhD degree in Applied Microbiology from Indian Institute of Technology Delhi, New Delhi, India where he studied the antimicrobial potential of different phytochemicals against food spoiling and disease causing microorganisms in in-vivo and in-vitro food models. During his PhD, he was awarded for European grant ‘Erasmus Mundus Corporation Window’ for doing part of his thesis work in University of Bologna, Italy. His work at The university of Texas MD Anderson Cancer Center revealed that TNF exhibit pro-inflammatory activities and may mediate carcinogenesis through the activation of a transcription factor NF-κB. The gene products regulated by NF-κB have now been linked to cellular transformation, tumor cell survival, proliferation, invasion, angiogenesis, metastasis, chemoresistance, and radioresistance. Mostly carcinogens, tumor promoters, growth factors, inflammatory agents, chemotherapeutic agents, radiation, viruses, bacteria, cigarette smoke, alcohol and other life style factors activate NF-κB and another transcription factor STAT3. DrTyagi’s research group is working on safe and multi-targeting chemopreventive agents derived from natural resources suppress NF-κB and STAT3 pathway and suppress tumorigenesis.

 Biography
Research Interest :

Study of transcription factors NF-kappaB and STAT3 signaling pathway, death receptor pathway, extrinsic and intrinsic pathway of apoptosis, anticancer properties of natural compounds in both in vitro and nude mouse models, study of cell cycle by flow cytometry, study of oxidative stress in animal models, antioxidants, study of genotoxicity by chromosomal aberration and micronuclei assay, study of gene expression by using western blotting and RT-PCR, DNA binding assay by EMSA, reporter gene expression, Immunohistochemical analysis, studies on both in vivo and in vitro experimental models, SEM, TEM, AFM, Food Microbiology and Food Chemistry, SPME-GCMS.

 Research Interest
 Network
 Acceptance Letter
 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Materials Science Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version